Atlas Trials

A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

Clinical trial NCT03535649 · COMPLETED

Trial details

NCT number
NCT03535649
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Colitis, Ulcerative
Start date
2017-08-17
Primary completion
2018-12-18
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.